Search research articles
Contact Us
Filters
Showing results (621-630 of 644) with videos related to
Page
of 65
Sort By:
Developmental Cell
|
May 4, 2022
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
Harun Ozturk, Harun Cingoz, Turan Tufan, et al.
JAMA Oncology
|
January 27, 2018
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features
William L Hwang, Rahul D Tendulkar, Andrzej Niemierko, et al.
American Journal of Clinical Oncology
|
May 20, 2024
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma
Grace Lee, Daniel W Kim, Alicia C Smart, et al.
Immunity
|
September 17, 2021
Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1<sup>+</sup> CD8<sup>+</sup> T cells in tumor-draining lymph nodes
Jason M Schenkel, Rebecca H Herbst, David Canner, et al.
Cell Reports
|
April 28, 2026
GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinoma
Dennis Gong, Jimmy A Guo, Jennifer Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2021
Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection
Jimmy A Guo, Hannah I Hoffman, Stuti G Shroff, et al.
Annals of Neurology
|
November 21, 2020
Diagnostic Accuracy of Amyloid versus <sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia
Orit H Lesman-Segev, Renaud La Joie, Leonardo Iaccarino, et al.
The Oncologist
|
August 22, 2020
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers
Surendra Pal Chaudhary, Eunice L Kwak, Katie L Hwang, et al.
The EMBO Journal
|
October 24, 2018
Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth
Andrew G Cox, Allison Tsomides, Dean Yimlamai, et al.
Cancer Cell
|
August 6, 2021
The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer
William A Freed-Pastor, Laurens J Lambert, Zackery A Ely, et al.
Page
of 65
Search research articles
Search
Showing results (621-630 of 644) with videos related to
Sort By:
Page
of 65
Developmental Cell
|
May 4, 2022
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
Harun Ozturk, Harun Cingoz, Turan Tufan, et al.
JAMA Oncology
|
January 27, 2018
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features
William L Hwang, Rahul D Tendulkar, Andrzej Niemierko, et al.
American Journal of Clinical Oncology
|
May 20, 2024
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma
Grace Lee, Daniel W Kim, Alicia C Smart, et al.
Immunity
|
September 17, 2021
Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1<sup>+</sup> CD8<sup>+</sup> T cells in tumor-draining lymph nodes
Jason M Schenkel, Rebecca H Herbst, David Canner, et al.
Cell Reports
|
April 28, 2026
GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinoma
Dennis Gong, Jimmy A Guo, Jennifer Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2021
Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection
Jimmy A Guo, Hannah I Hoffman, Stuti G Shroff, et al.
Annals of Neurology
|
November 21, 2020
Diagnostic Accuracy of Amyloid versus <sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia
Orit H Lesman-Segev, Renaud La Joie, Leonardo Iaccarino, et al.
The Oncologist
|
August 22, 2020
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers
Surendra Pal Chaudhary, Eunice L Kwak, Katie L Hwang, et al.
The EMBO Journal
|
October 24, 2018
Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth
Andrew G Cox, Allison Tsomides, Dean Yimlamai, et al.
Cancer Cell
|
August 6, 2021
The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer
William A Freed-Pastor, Laurens J Lambert, Zackery A Ely, et al.
Page
of 65